Currently out of the existing stock ratings of Justin Bowers, 59 are a BUY (76.62%), 18 are a HOLD (23.38%).

Justin Bowers

Work Performance Price Targets & Ratings Chart

Analyst Justin Bowers, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 64.88% that have a potential upside of 26.09% achieved within 167 days.

Justin Bowers’s has documented 152 price targets and ratings displayed on 14 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on IQV, IQVIA Holdings at 01-Nov-2024.

Wall Street Analyst Justin Bowers

Analyst best performing recommendations are on AVTR (AVANTOR).
The best stock recommendation documented was for AVTR (AVANTOR) at 12/12/2023. The price target of $22 was fulfilled within 2 days with a profit of $0.74 (3.48%) receiving and performance score of 17.4.

Average potential price target upside

AMED Amedisys LHCG LHC Group SEM Select Medical Holdings ICLR ICON PLC SYNH Syneos Health CRL Charles River Laboratories CTLT Catalent MRVI Maravai Lifesciences Holdings  ABCM Abcam PLC AVTR Avantor DHR Danaher RGEN Repligen IQV IQVIA Holdings TMO Thermo Fisher Scientific

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$101

$10.56 (11.68%)

$101

3 months 24 days ago
(31-Jul-2024)

3/10 (30%)

$2.95 (3.01%)

70

Hold

$101

$10.56 (11.68%)

$101

3 months 30 days ago
(25-Jul-2024)

1/8 (12.5%)

$3.25 (3.32%)

45

Hold

7 months 29 days ago
(26-Mar-2024)

5/10 (50%)

$12.13 (9.49%)

99

Hold

$101

$10.56 (11.68%)

$84

1 years 3 months 24 days ago
(31-Jul-2023)

1/3 (33.33%)

$10.16 (11.18%)

28

Hold

$101

$10.56 (11.68%)

$100

1 years 3 months 28 days ago
(27-Jul-2023)

0/5 (0%)

$10.5 (11.60%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Justin Bowers is most bullish on?

Potential upside of $63.18 has been obtained for IQV (IQVIA HOLDINGS)

Which stock is Justin Bowers is most reserved on?

Potential downside of $10.56 has been obtained for AMED (AMEDISYS)

What Year was the first public recommendation made by Justin Bowers?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?